The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015
Open accessAbstract
Rationale: Estimating the annual incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease may assist in improving understanding of the public health and economic impacts of this disease and its treatment. Objective: To estimate the yearly incidence and prevalence of administrative claims–based NTM lung disease between 2008 and 2015 in a U.S. managed care claims database. Methods: We used a national managed care claims database (Optum Clinformatics Data Mart) representing a geographically diverse population of approximately 27 million members annually. All medical claims from January 1, 2007, to June 30, 2016, were scanned for diagnosis codes for NTM lung disease (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 031.0 or ICD-10-CM code A31.0). We defined a case of NTM lung disease as having at least two medical claims with a code of 031.0 or A31.0 that were dated at least 30 days apart. Annual incidence and prevalence were estimated for each calendar year from 2008 to 2015. Results: From 2008 to 2015, the annual incidence of NTM lung disease increased from 3.13 (95% confidence interval [CI], 2.88–3.40) to 4.73 (95% CI, 4.43–5.05) per 100,000 person-years, and the annual prevalence increased from 6.78 (95% CI, 6.45–7.14) to 11.70 (95% CI, 11.26–12.16) per 100,000 persons. The average annual changes in incidence and prevalence were +5.2% (95% CI, 4.0–6.4%; P < 0.01) and +7.5% (95% CI, 6.7–8.2%; P < 0.01), respectively. For women, the annual incidence increased from 4.16 (95% CI, 3.76–4.60) to 6.69 (95% CI, 6.19–7.22) per 100,000 person-years, and the annual prevalence increased from 9.63 (95% CI, 9.08–10.22) to 16.78 (95% CI, 16.04–17.55) per 100,000 persons. For individuals aged 65 years or older, the annual incidence increased from 12.70 (95% CI, 11.46–14.07) to 18.37 (95% CI, 16.98–19.87) per 100,000 person-years, and the annual prevalence increased from 30.27 (95% CI, 28.41–32.24) to 47.48 (95% CI, 45.37–49.67) per 100,000 persons. The incidence and prevalence of NTM lung disease increased in most U.S. states and overall at the national level. Conclusions: The incidence and prevalence of NTM lung disease appears to be increasing in the United States, particularly among women and older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationEpidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
Prevots, D. R., & Marras, T. K. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.10.002 · Cited by 920
Self-citationHaworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210927 · Cited by 785
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M., & Prevots, D. R. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2016oc · Cited by 690
Self-citationNontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis
Olivier, K. N., Weber, D. J., Wallace, R. J., Faiz, A. R., Lee, J.-H., Zhang, Y., Brown-Elliot, B. A., Handler, A., Wilson, R. W., Schechter, M. S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-678oc · Cited by 631
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., Montes de Oca, R., Shea, Y. R., Seitz, A. E., Holland, S. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0310oc · Cited by 582
Pulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting Syndrome
Kim, R. D., Greenberg, D. E., Ehrmantraut, M. E., Guide, S. V., Ding, L., Shea, Y., Brown, M. R., Chernick, M., Steagall, W. K., Glasgow, C. G., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-686oc · Cited by 444
Winthrop, K. L., McNelley, E., Kendall, B., Marshall-Olson, A., Morris, C., Cassidy, M., Saulson, A., & Hedberg, K. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0503oc · Cited by 414
Self-citationTrends in Bronchiectasis Among Medicare Beneficiaries in the United States, 2000 to 2007
Seitz, A. E., Olivier, K. N., Adjemian, J., Holland, S. M., & Prevots, D. R. (2012) · Chest · doi:10.1378/chest.11-2209 · Cited by 318
Self-citationChanging Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections
Thomson, R. M., on behalf of the NTM working group at the Queensland TB Control Centre, & Laboratory, Q. M. R. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1610.091201 · Cited by 283
DRG Creep: A New Hospital-Acquired Disease
Simborg, D. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042611 · Cited by 272
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000242 · Cited by 253
Update on the Epidemiology of Pulmonary Nontuberculous Mycobacterial Infections
Kendall, B., & Winthrop, K. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1333567 · Cited by 220
Self-citationPulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010
Marras, T. K., Mendelson, D., Marchand-Austin, A., May, K., & Jamieson, F. B. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1911.130737 · Cited by 210
Self-citationPopulation-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012
Henkle, E., Hedberg, K., Schafer, S., Novosad, S., & Winthrop, K. L. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-559oc · Cited by 175
Self-citationPulmonary Disease Caused by Non-Tuberculous Mycobacteria
Wassilew, N., Hoffmann, H., Andréjak, C., & Lange, C. G. (2016) · Respiration · doi:10.1159/000445906 · Cited by 160
Mirsaeidi, M., Machado, R. F., Garcia, J. G. N., & Schraufnagel, D. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091879 · Cited by 159
The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States
Strollo, S. E., Adjemian, J., Adjemian, M. K., & Prevots, D. R. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201503-173oc · Cited by 158
Self-citationShah, N. M., Davidson, J. A., Anderson, L., Lalor, M. K., Kim, J., Thomas, H. L., Lipman, M. C. I., & Abubakar, I. I. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1521-3 · Cited by 157
Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014
Ringshausen, F. C., Wagner, D., Roux, A. D., Diel, R., Hohmann, D., Hickstein, L., Welte, T., & Rademacher, J. (2016) · Emerging infectious diseases · doi:10.3201/eid2206.151642 · Cited by 151
Burden of non-tuberculous mycobacterial pulmonary disease in Germany
Diel, R., Jacob, J., Lampenius, N., Loebinger, M. R., Nienhaus, A., Rabe, K. F., & Ringshausen, F. C. (2017) · European Respiratory Journal · doi:10.1183/13993003.02109-2016 · Cited by 147
Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008–2013
Donohue, M. J., & Wymer, L. J. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-353oc · Cited by 136
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis
Mirsaeidi, M. S., Hadid, W., Ericsoussi, B., Rodgers, D. E., & Sadikot, R. T. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.03.018 · Cited by 130
Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013
Marras, T. K., Campitelli, M. A., Lu, H., Chung, H., Brode, S. K., Marchand‐Austin, A., Winthrop, K. L., Gershon, A. S., Kwong, J. C., & Jamieson, F. (2017) · Emerging infectious diseases · doi:10.3201/eid2303.161927 · Cited by 87
Self-citationPrevalence and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in the United States
Biener, A. I., Decker, S. L., & Rohde, F. C. (2019) · JAMA · doi:10.1001/jama.2019.10241 · Cited by 78
Boyle, D. P., Zembower, T., & Qi, C. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-344bc · Cited by 75
Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999–2014
Vinnard, C., Longworth, S. A., Mezochow, A. K., Patrawalla, A., Kreiswirth, B. N., & Hamilton, K. W. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-474bc · Cited by 74
Winthrop, K. L., Baxter, R. P., Liu, L., McFarland, B. H., Austin, D., Varley, C. D., Radcliffe, L., Suhler, E. B., Choi, D., & Herrinton, L. J. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2049 · Cited by 73
Self-citationAl‐Houqani, M., Jamieson, F., Mehta, M., Chedore, P., May, K., & Marras, T. K. (2011) · CHEST Journal · doi:10.1378/chest.11-0089 · Cited by 59
Self-citationO’Connell, M. L., Birkenkamp, K. E., Kleiner, D. E., Folio, L. R., Holland, S. M., & Olivier, K. N. (2011) · CHEST Journal · doi:10.1378/chest.11-0425 · Cited by 55
Cited by
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
Dahl, V. N., Mølhave, M., Fløe, A., van Ingen, J., Schön, T., Lillebaek, T., Andersen, A. B., & Wejse, C. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.013 · Cited by 329
Ribosomal protection as a linezolid resistance mechanism in Mycobacterium abscessus
Funck, T., McGowen, K., Sullivan, M. R., Zinga, S., Wolf, I. D., Nurjadi, D., Denkinger, C. M., & Rubin, E. J. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01605-25 · Cited by 1
Metadata
- Authors
- Winthrop, K. L., Marras, T. K., Adjemian, J., Zhang, H., Wang, P., & Zhang, Q.
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-01
- Volume
- 17
- Issue
- 2
- Pages
- 178-185
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- OpenAlex
- W2995199373
- Cited by
- 334
- References
- 30
- FWCI
- 17.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.